Cargando…
Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1
BACKGROUND: Cystic fibrosis (CF) is characterized by a progressive decline in lung function due to airway obstruction, infection, and inflammation. CF patients are particularly susceptible to respiratory infection by a variety of pathogens, and the inflammatory response in CF is dysregulated and pro...
Autores principales: | Saferali, Aabida, Tang, Anthony C., Strug, Lisa J., Quon, Bradley S., Zlosnik, James, Sandford, Andrew J., Turvey, Stuart E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957340/ https://www.ncbi.nlm.nih.gov/pubmed/31931521 http://dx.doi.org/10.1371/journal.pone.0227067 |
Ejemplares similares
-
Longer Telomere Length in COPD Patients with α(1)-Antitrypsin Deficiency Independent of Lung Function
por: Saferali, Aabida, et al.
Publicado: (2014) -
Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016) -
Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013) -
A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus
por: Wang, Fan, et al.
Publicado: (2022) -
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)